Family History Colorectal Cancer Risk IBD
Analysis based on 9 articles · First reported Sep 03, 2026 · Last updated Sep 04, 2026
The study may influence future colorectal cancer screening guidelines for IBD patients, potentially affecting diagnostic and monitoring practices. This could impact healthcare providers, diagnostic companies, and pharmaceutical firms developing treatments for IBD and colorectal cancer, though immediate market effects are likely limited.
A Swedish registry study from Karolinska Institutet, published in Gastroenterology, found that people with inflammatory bowel disease (IBD) who have two or more first-degree relatives with colorectal cancer face about 2.6 times the risk of developing the disease themselves, compared to IBD patients without such family history. The study included 124,387 people with IBD in Sweden between 1996 and 2023, followed for a median of eleven years, during which 1,882 developed colorectal cancer. In contrast, IBD patients with a first-degree relative diagnosed before age 50 had only a just under 50% higher risk. The findings suggest that the number of affected relatives may be a more important risk marker than the age of diagnosis, potentially influencing future screening guidelines. The study used Swedish national registers including the Patient Register, Cancer Register, Cause of Death Register, Multigenerational Register, and the ESPRESSO cohort. Funding came from Sweden — Swedish Research Council, American Cancer Society, Sweden — Vinnova, Sweden — Stockholm County, Karolinska Institutet, and ERA PerMed. The research is observational and does not prove causation, but highlights the importance of detailed family history in risk assessment for IBD patients.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard